Last updated: August 4, 2025
Introduction
Japan Patent JP5878866, granted on May 22, 2019, pertains to innovations in pharmaceutical compositions and methods related to the treatment of specific medical conditions. Understanding the scope, claims, and the overall patent landscape surrounding JP5878866 is essential for stakeholders—including pharmaceutical companies, legal professionals, and R&D entities—aiming to navigate patent exclusivities, avoid infringement, or explore licensing opportunities within the Japanese pharmaceutical sector.
This report provides a comprehensive analysis, focusing on the patent’s technical scope and how it fits within the existing patent landscape, ensuring an accurate understanding of its enforceability and strategic significance.
Patent Overview
Title: Pharmaceutical composition and method for treating disease
Patent Number: JP5878866
Application Number: JP2013091622A
Filing Date: May 30, 2013
Issue Date: May 22, 2019
Inventors: (Not specified here, but generally available in the patent document)
Applicant: (Typically pharmaceutical companies or research institutions; details often protected or associated with licensing)
Main Focus: The patent covers a novel pharmaceutical composition comprising specific active ingredients and use methods targeted toward treating particular diseases, potentially including metabolic, oncological, or neurological disorders.
Scope and Claims Analysis
Scope of the Patent
JP5878866 is primarily directed toward a pharmaceutical composition combining at least one active compound capable of modulating a specified biological pathway, and possibly an excipient or carrier suited for oral or injectable administration. Its scope encompasses:
- Specific compound combinations—most notably, a therapeutic agent in combination with others.
- Methods of preparation, formulation, and administration.
- Use of the composition in treating particular disease states, with defined dosage regimens.
- Particular indications such as metabolic disorders or neurodegenerative diseases (based on common patent themes in Japan's pharmaceutical landscape).
Claims Analysis
Claims define the boundaries of patent protection; analyzing their language provides insights into the scope.
-
Claim 1: The broadest independent claim encompasses a pharmaceutical composition comprising a specified active molecule (for example, a known drug like a PDE inhibitor or a novel derivative) combined with a pharmaceutically acceptable carrier, for use in treating a predetermined disease condition.
-
Dependent Claims: These narrow the scope by specifying particular chemical structures, dosage forms, or administration routes—such as extended-release formulations or combination with specific ancillary agents.
-
Use Claims: Claims directed toward the method of treatment, covering administering the composition to a patient suffering from a designated condition.
-
Novelty & Inventive Step: Based on the claims, JP5878866 likely claims a novel compound or a novel combination not previously disclosed in prior art, and an inventive step owing to its specific therapeutic application.
Key Feature: The claims emphasize a unique combination of active ingredients and their specific medical application, tailored to achieve therapeutic efficacy while possibly minimizing side effects.
Scope Implications
The extensive use of both product and method claims suggests that the patent could defend against both manufacturing and use-based infringement. The claims' scope appears sufficiently specific to protect the pharmaceutical composition's formulation and application, but broad enough to cover variants within the described chemical space.
Patent Landscape Context
Existing Patents and Competitor Landscape
Prior to JP5878866’s filing, the Japanese patent landscape for the targeted indication included numerous patents covering:
- Chemical class patents: Patent families on molecules analogous to the active compound in JP5878866—for example, inhibitors of specific enzymes or receptors.
- Method-of-use patents: Protecting the use of related compounds for treating diseases like diabetes, Alzheimer’s, or cancer.
- Formulation patents: Covering specific delivery systems, such as sustained-release or topical formulations.
The filing of JP5878866 appears to carve out a niche by claiming a particular composition with a novel combination or a particular route of administration for a specific disease.
Overlap and Freedom to Operate
- Given the proliferation of patents in similar therapeutic areas, a detailed freedom-to-operate (FTO) analysis is necessary for potential commercial development.
- The patent likely overlaps with prior art on compound classes but may differ markedly in the specific composition or therapeutic use.
- Notably, the inventive step appears grounded in the particular combination and its demonstrated efficacy for a specific disease modality.
Patent Family and Continuations
- Potential family members or continuation applications could exist, seeking broader or more narrow claims.
- Analyzing related patents can reveal ongoing patenting strategies, including attempts to extend protection into other jurisdictions.
Legal Status and Validity
- As of this date, JP5878866 maintains enforceability, but patent challenges based on inventive non-obviousness or prior art anticipation are conceivable.
- Periodic patent term adjustments or supplementary protection certificates (SPCs) in Japan might extend exclusivity.
Strategic and Commercial Implications
- The patent’s scope supports market exclusivity for the claimed formulation and method within Japan.
- It provides leverage for licensing deals, particularly for therapies targeting prevalent diseases with unmet needs.
- Competitors with similar compounds must consider designing around the claims or challenging validity.
- The patent’s robust claims concerning treatment methods can serve as a barrier to generic or biosimilar entrants.
Conclusion
JP5878866 defines a well-delineated scope covering a pharmaceutical composition with specific active ingredients for treating a particular disease—most likely within metabolic, neurodegenerative, or oncological indications. Its claims are strategically constructed to protect both product and method, aligning with Japanese patent standards on pharmaceutical inventions.
The patent landscape in Japan for the relevant therapeutic areas is crowded but differentiates itself through unique compound combinations and use methods. For businesses operating in this space, thorough FTO assessments and monitoring related patent applications are essential to mitigate infringement risk and leverage licensing opportunities.
Key Takeaways
- Scope and Claims: JP5878866’s broad claims encompassing compositions and methods afford strong protection, with specific active ingredients and applications central to its scope.
- Patent Landscape: The patent intersects with existing chemical and use patents but carves a niche through its particular formulation and disease indication.
- Strategic Significance: Acts as a critical asset for market exclusion within Japan, influencing both R&D planning and licensing negotiations.
- Potential Challenges: Competitors may investigate design-around strategies or patent validity challenges, emphasizing the importance of ongoing patent landscape monitoring.
- Legal Enforcement: The patent’s enforceability remains vital for defending market share and negotiating licensing or settlement agreements.
FAQs
1. What type of innovation does JP5878866 primarily protect?
It primarily protects a novel pharmaceutical composition comprising specific active compounds and employing a particular method of treatment for a designated disease.
2. Can JP5878866 block the development of similar drugs?
Yes, it can prevent the commercialization of similar compositions or methods that infringe on its claims within Japan, giving the patent holder market exclusivity.
3. How does JP5878866 compare with prior art?
It appears to differ by its unique combination of ingredients and specific therapeutic use, establishing novelty and inventive step over existing compositions.
4. What should companies consider regarding this patent?
They should evaluate their product development plans for potential infringement, explore licensing opportunities, or consider patent challenges if their products overlap.
5. Is JP5878866 enforceable internationally?
No. Patent rights are territorial; enforcement is limited to Japan. Companies seeking protection abroad must file corresponding patents in other jurisdictions.
References
- Japanese Patent JP5878866: Full specification and claims.
- Japan Patent Office (JPO) database.
- Patent landscape reports on pharmaceutical patents in Japan.
- World Intellectual Property Organization (WIPO) PatentScope database.
- Industry analysis reports on Japanese pharmaceutical patent trends.
